Dr. Aydin H. Pooli, MD

Dr. Pooli practices at S. Adam Ramin MD Inc in North Hollywood, California.

Dr. Pooli's NPI, 1548558067, was assigned on July 18, 2011. Dr. Pooli graduated from Tehran University of Medical Sciences School of Medicine in 2004. Dr. Pooli holds California license A142512.

Dr. Pooli's primary practice is S. Adam Ramin MD Inc, at 12922 W Victory Blvd, North Hollywood, CA 91606 in Los Angeles County. The practice phone is (310) 284-8191.

Dr. Pooli's primary practice is S. Adam Ramin MD Inc in North Hollywood, California. Dr. Pooli is also affiliated with Olive View-UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Pooli to 5 more hospitals, 11 medical groups, 8 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pooli practices, 15 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Pooli's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Pooli is board certified in urology by the American Board of Urology. Dmand AI has Dr. Pooli's licenses on file in 4 states: California, Oregon, Nebraska and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Pooli treats.

CMS data shows 677 Medicare services from Dr. Pooli across 15 procedure codes in 2024, for 339 Medicare patients. Medicare paid $116,558 for them. Every service was in an office.

CMS counts 339 Medicare patients who saw Dr. Pooli in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 82% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pooli's median patient age at 63, with 37% women.

In 2024, Dr. Pooli wrote 2,325 Medicare Part D claims for 526 patients. 92% of them were for generic drugs. CMS names the drug for 2,240 of them, across 20 drugs with 11 or more claims each, at $262,338 in total drug cost. In 2023, CMS named 2,327 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Pooli for performance year 2024, reported as part of a group. CMS lists Dr. Pooli as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Pooli, published from 2011 to 2019. 2018 was the busiest year, with 3. Dr. Pooli's most frequent co-authors are Alexandra Drakaki, MD, Allan Pantuck, MD and Shima Aran, MD.

CMS Open Payments shows 172 general payments to Dr. Pooli from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. MIMEDX Group, Inc. paid the most, $1,936.

Dr. Pooli graduated from Tehran University of Medical Sciences School of Medicine in 2004. Dr. Pooli is a member of ACS and AUA.

Dr. Pooli is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.